Ibrahim H, McKenna M J, Feldkamp C S
Division of Endocrinology and Metabolism, Henry Ford Hospital, Detroit, MI 48202.
Henry Ford Hosp Med J. 1991;39(1):30-4.
We conducted a pilot study to evaluate an algorithm for thyroid function testing consisting of initial serum thyrotropin values, measured by a sensitive immunoradiometric assay (TSH-IRMA), followed by a computer-directed decision to order further studies. We divided 216 outpatients according to their serum TSH-IRMA values as follows: suppressed (less than 0.1 mU/L, group I); low (0.1 to 0.4 mU/L, group II); normal (0.5 to 5.0 mU/L, group III); and high (greater than 5.0 mU/L, group IV). Thyroxine (T4), resin uptake (RU), and free thyroxine index (FTI) tests on groups I, II, and IV revealed that T4 and RU were normal for most patients in all groups and FTI was normal in 80% of group I, 93.4% of group II, and 93.3% of group IV. All patients in group I were designated hyperthyroid from either an exogenous or endogenous source. All patients in group II were clinically euthyroid except one; 50% were taking either L-thyroxine or propylthiouracil and 50% had no identifiable thyroid disease. Patients in group IV were hypothyroid. Overall, TSH was more effective in detecting both hypothyroidism and hyperthyroidism than either serum T4, RU ratio, or both combined in FTI since results of these measures fell in the normal range for most patients in all groups.(ABSTRACT TRUNCATED AT 250 WORDS)
我们开展了一项初步研究,以评估一种甲状腺功能检测算法,该算法包括通过灵敏免疫放射分析(TSH-IRMA)测量初始血清促甲状腺激素值,随后由计算机指导决定是否进行进一步检查。我们根据血清TSH-IRMA值将216名门诊患者分为以下几组:受抑制组(低于0.1 mU/L,第一组);低值组(0.1至0.4 mU/L,第二组);正常组(0.5至5.0 mU/L,第三组);高值组(高于5.0 mU/L,第四组)。对第一、二和四组进行甲状腺素(T4)、树脂摄取率(RU)和游离甲状腺素指数(FTI)检测,结果显示,所有组的大多数患者T4和RU均正常,第一组80%、第二组93.4%、第四组93.3%的患者FTI正常。第一组所有患者均被认定为外源性或内源性甲状腺功能亢进。第二组除一名患者外,所有患者临床甲状腺功能正常;50%的患者正在服用左甲状腺素或丙硫氧嘧啶,50%的患者无明确的甲状腺疾病。第四组患者为甲状腺功能减退。总体而言,TSH在检测甲状腺功能减退和亢进方面比血清T4、RU比值或FTI中两者联合检测更有效,因为所有组中大多数患者这些指标的结果均在正常范围内。(摘要截选至250词)